Enhanced phenotypic expression of alpha-1-antitrypsin deficiency in an MZ heterozygote with chronic hepatitis C

American Journal of Gastroenterology

Volumn 93, Issue 9, 1998, Pages 1541-1545

  Banner, Barbara F ^a   Karamitsios, Nicholas ^a   Smith, Lynda ^a   Bonkovsky, Herbert L ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT ALPHA2A INTERFERON;

ADULT; ALPHA 1 ANTITRYPSIN DEFICIENCY; ARTICLE; CASE REPORT; CHRONIC HEPATITIS; FEMALE; GENE EXPRESSION; HEPATITIS C; HETEROZYGOSITY; HISTOPATHOLOGY; HUMAN; IMMUNOTHERAPY; LIVER BIOPSY; PHENOTYPE; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; TREATMENT OUTCOME;

ADULT; ALANINE TRANSAMINASE; ALPHA 1-ANTITRYPSIN DEFICIENCY; ANTIVIRAL AGENTS; ASPARTATE AMINOTRANSFERASES; BIOPSY; HEPATITIS C, CHRONIC; HETEROZYGOTE; HUMANS; INTERFERON-ALPHA; LIVER; MALE; PHENOTYPE;

EID: 0032173068     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1572-0241.1998.00478.x     Document Type: Article

References (18)

1. 1. Hodges JR, Millward-Sadler GH, Barbatis C, et al. Heterozygous MZ alpha 1-antitrypsin deficiency in adults with chronic active hepatitis and cryptogenic cirrhosis. N Engl J Med 1981;304:557-60.
2. 2. Eriksson S. α1-Antitrypsin deficiency and liver cirrhosis in adults. An analysis of 35 Swedish autopsied cases. Acta Med Scand 1987;221: 461-7.
3. 3. Cox DW, Smith S. Risk for liver disease in adults with alpha 1-antitrypsin deficiency. Am J Med 1983;74:221-7.
4. 4. Elzouki AN, Eriksson S. Risk of hepatobiliary disease in adults with severe α1-antitrypsin dificiency (PiZZ): Is chronic viral hepatitis B or C an additional risk factor for cirrhosis and hepatocellular carcinoma? Eur J Gastroenterol Hepatol 1996;8:989-994.
5. 5. Vogel W, Propst T, Propst A, et al. Causes of liver disease in an adult population with heterozygous and homozygous alpha-1-antitrypsin deficiency. Acta Paediatr 1994;393(suppl):24-6.
6. 6. Massi G. Pathogenesis and pathology of liver disease associated with α1-antitrypsin deficiency. Chest 1996;110:251S-5S.
7. 7. Propst T, Propst A, Dietze O, et al. High prevalence of viral infection in adults with homozygous and heterozygous alpha 1-antitrypsin deficiency and chronic liver disease. Ann Intern Med 1992;117:641-5.
8. 8. Propst T, Propst A, Dietze O, et al. Alpha-1-antitrypsin deficiency and liver disease. Dig Dis 1994;12:139-49.
9. 9. Nemeth A. Pathogenesis of liver disease in alpha 1-antitrypsin deficiency. Acta Paediatr 1994;393(suppl):5-7.
10. 10. Qizilbash A, Young-Pong O. Alpha 1 antitrypsin liver disease differential diagnosis of PAS-positive, diastase-resistant globules in liver cells. Am J Clin Pathol 1983;79:697-702.
11. 11. Breit SN, Robinson JP, Luckhurst E, et al. Immunoregulation by α1 antitrypsin. J Clin Lab Immunol 1982:7:127-31.
12. 12. Breit SN, Wakefield D, Robinson JP, et al. The role of a1-antitrypsin deficiency in the pathogenesis of immune disorders. Clin Immunol Immunopathol 1985;35:363-80.
13. 13. Teckman JH, Dongfeng Q, Perlmutter DH. Molecular pathogenesis of liver disease in α1-antitrypsin deficiency. Hepatology 1996;24:1504-16.
14. 14. Combs C, Brunt E, Solomon H, et al. Rapid development of hepatic α1-antitrypsin globules after liver transplantation for chronic hepatitis C. Gastroenterology 1997;112:1372-5.
15. 15. Dubuisson J, Rice CM. Hepatitis C virus glycoprotein folding: Disulfide bond formation and association with calnexin. J Virol 1996;70: 778-86.
16. 16. Bonkovsky HL, Banner BF, Rothman AL. Iron and chronic viral hepatitis. Hepatology 1997;25:759-68.
17. 17. Fargion S, Bissoli F, Ludovica A, et al. No association between genetic hemochromatosis and α1-antitrypsin deficiency. Hepatology 1996;24: 1161-4.
18. 18. Gehrke SG, Riedel HD, Fitscher BA, et al. Prevalence of mutations in the hemochromatosis gene HLA-H in patients with chronic hepatitis C: Influence of histological activity, iron metabolism, and response to Interferon therapy. Hepatology 1997;26:410A.